Bile Acids and Farnesoid X Receptor in Renal Pathophysiology
Authors:
- Jiufang YangJYJiufang Yang
- Marco PontoglioMPMarco Pontoglio
- Fabiola TerziFTFabiola Terzi
Open Access
- 27 February 2024
- journal article
- review article
- Published by S. Karger AG in Nephron
- Vol. 148 (9) , 618-630
Abstract
Background: Bile acids (BAs) act not only as lipids and lipid-soluble vitamin detergents but also function as signaling molecules, participating in diverse physiological processes. The identification of BA receptors in organs beyond the enterohepatic system, such as the farnesoid X receptor (FXR), has initiated inquiries into their organ-specific functions. Among these organs, the kidney prominently expresses FXR. Summary: This review provides a comprehensive overview of various BA species identified in kidneys and delves into the roles of renal apical and basolateral BA transporters. Furthermore, we explore changes in BAs and their potential implications for various renal diseases, particularly chronic kidney disease. Lastly, we center our discussion on FXR, a key BA receptor in the kidney and a potential therapeutic target for renal diseases, providing current insights into the protective mechanisms associated with FXR agonist treatments. Key Messages: Despite the relatively low concentrations of BAs in the kidney, their presence is noteworthy, with rodents and humans exhibiting distinct renal BA compositions. Renal BA transporters efficiently facilitate either reabsorption into systemic circulation or excretion into the urine. However, adaptive changes in BA transporters are evident during cholestasis. Various renal diseases are accompanied by alterations in BA concentrations and FXR expression. Consequently, the activation of FXR in the kidney could be a promising target for mitigating kidney damage.Keywords
This publication has 100 references indexed in Scilit:
- Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal modelActa Diabetologica, 2021
- Animal models to study bile acid metabolismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acidsAnaerobe, 2017
- Mechanism underlying an elevated serum bile acid level in chronic renal failure patientsInternational Urology and Nephrology, 2014
- Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidneyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Bile acids trigger cholemic nephropathy in common bile-duct-ligated miceHepatology, 2013
- Mouse Organic Solute Transporter α Deficiency Enhances Renal Excretion of Bile Acids and Attenuates CholestasisHepatology, 2009
- Expression of rat renal cortical OAT1 and OAT3 in response to acute biliary obstructionHepatology, 2006
- Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasisHepatology, 2006
- OSTα‐OSTβHepatology, 2005